We are analyzing https://link.springer.com/article/10.1007/s11888-012-0146-1.

Title:
Lipoxygenase and Cyclooxygenase Pathways and Colorectal Cancer Prevention | Current Colorectal Cancer Reports
Description:
Colorectal cancer is one of the commonest malignancies in both men and women. In spite of significant progress in screening and in surgical and therapeutic interventions, colorectal cancer (CRC) is still a major public health problem. Accumulating evidence suggests that targeting inflammatory pathways may provide protection against the development of CRC. Eicosanoids derived from the enzymes cyclooxygenase (COX) and lipoxygenase (LOX) may contribute to CRC carcinogenesis. Approaches for targeting COX-1 and COX-2 with traditional nonsteroidal anti-inflammatory agents or targeting COX-2 with specific inhibitors are highly successful at the preclinical and clinical levels; however, large-scale clinical applicability of these agents is limited owing to unwanted side effects. Emerging studies suggests that 5-LOX-derived leukotrienes may contribute to colon tumor development and risk of thrombotic events. Thus, developing drugs that target both 5-LOX and COX-2 may provide a safer strategy. In this review, we discuss evidence for the involvement of 5-LOX in colon tumor development and targeting 5-LOX and COX-2 with synthetic and naturally occurring agents for CRC prevention.
Website Age:
28 years and 1 months (reg. 1997-05-29).

Matching Content Categories {📚}

Health & Fitness
Education
Science

Content Management System {📝}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month

Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {💸}

We don’t know how the website earns money.

Websites don't always need to be profitable; some serve as platforms for education or personal expression. Websites can serve multiple purposes. And this might be one of them. Link.springer.com might be cashing in, but we can't detect the method they're using.

Keywords {🔍}

google, scholar, cancer, cas, article, pubmed, colon, lipoxygenase, res, human, colorectal, cyclooxygenase, rao, prevention, inhibitors, cox, carcinogenesis, chemoprevention, med, reddy, cell, celecoxib, effect, inhibition, lox, cells, inhibitor, engl, leukotriene, dual, leukotrienes, potential, growth, antiinflammatory, effects, risk, eicosanoid, pathway, acid, nature, privacy, cookies, content, janakiram, mohammed, crc, evidence, development, agents, signaling,

Topics {✒️}

steroidal anti-inflammatory drugs nonsteroidal anti-inflammatory agent acylnitroso hetero-diels-alder cycloadducts polyunsaturated fatty acids month download article/chapter omega-3 eicosapentaenoic acid anti-inflammatory therapy impaired coated-platelet formation azoxymethane-induced colon cancer dual 5-lox/cox inhibitor large-scale clinical applicability 5-lipoxygenase-activating protein azoxymethane-induced colon carcinogenesis anti-tumor activity potent dual inhibitors full article pdf complex eicosanoid interactions altered eicosanoid levels murine mast cells small intestinal tumorigenesis colorectal cancer prevention janakiram & altaf mohammed carcinogen-induced mutagenicity suppresses cell proliferation colorectal cancer incidence eicosanoid signaling privacy choices/manage cookies colorectal adenoma prevention azoxymethane-induced biochemical sporadic colorectal adenomas platelet procoagulant activity targeting inflammatory pathways 5-lipoxygenase translocation inhibitors developing drugs naturally occurring agents cell survival factors acetic acids specific cyclooxygenase-2 inhibitor human brain tumors article rao increased cyclooxygenase-2 levels familial adenomatous polyposis selective biochemical inhibitors cell-cell interaction large bowel cancer reddy bs colon cancer prevention check access instant access a23187 induces translocation

Questions {❓}

Neutrophils, endothelial cells, and cysteinyl leukotrienes: a new approach to neutrophil-dependent inflammation?

Schema {🗺️}

WebPage:
      mainEntity:
         headline:Lipoxygenase and Cyclooxygenase Pathways and Colorectal Cancer Prevention
         description:Colorectal cancer is one of the commonest malignancies in both men and women. In spite of significant progress in screening and in surgical and therapeutic interventions, colorectal cancer (CRC) is still a major public health problem. Accumulating evidence suggests that targeting inflammatory pathways may provide protection against the development of CRC. Eicosanoids derived from the enzymes cyclooxygenase (COX) and lipoxygenase (LOX) may contribute to CRC carcinogenesis. Approaches for targeting COX-1 and COX-2 with traditional nonsteroidal anti-inflammatory agents or targeting COX-2 with specific inhibitors are highly successful at the preclinical and clinical levels; however, large-scale clinical applicability of these agents is limited owing to unwanted side effects. Emerging studies suggests that 5-LOX-derived leukotrienes may contribute to colon tumor development and risk of thrombotic events. Thus, developing drugs that target both 5-LOX and COX-2 may provide a safer strategy. In this review, we discuss evidence for the involvement of 5-LOX in colon tumor development and targeting 5-LOX and COX-2 with synthetic and naturally occurring agents for CRC prevention.
         datePublished:2012-10-03T00:00:00Z
         dateModified:2012-10-03T00:00:00Z
         pageStart:316
         pageEnd:324
         sameAs:https://doi.org/10.1007/s11888-012-0146-1
         keywords:
            Lipoxygenase
            Cyclooxygenase
            Nonsteroidal anti-inflammatory drugs
            Eicosanoid
            Chemoprevention
            Dual cyclooxygenase/lipoxygenase inhibitors
            Curcumin
            Resolvins
            Omega-3 fatty acids
            Oncology
            Proctology
            Colorectal Surgery
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs11888-012-0146-1/MediaObjects/11888_2012_146_Fig1_HTML.gif
         isPartOf:
            name:Current Colorectal Cancer Reports
            issn:
               1556-3804
               1556-3790
            volumeNumber:8
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Current Science Inc.
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Chinthalapally V. Rao
               affiliation:
                     name:University of Oklahoma Health Sciences Center
                     address:
                        name:Center for Cancer Prevention and Drug Development, Medical Oncology, Department of Medicine, PC Stephenson Cancer Center, University of Oklahoma Health Sciences Center, Oklahoma City, USA
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
               name:Naveena B. Janakiram
               affiliation:
                     name:University of Oklahoma Health Sciences Center
                     address:
                        name:Center for Cancer Prevention and Drug Development, Medical Oncology, Department of Medicine, PC Stephenson Cancer Center, University of Oklahoma Health Sciences Center, Oklahoma City, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Altaf Mohammed
               affiliation:
                     name:University of Oklahoma Health Sciences Center
                     address:
                        name:Center for Cancer Prevention and Drug Development, Medical Oncology, Department of Medicine, PC Stephenson Cancer Center, University of Oklahoma Health Sciences Center, Oklahoma City, USA
                        type:PostalAddress
                     type:Organization
               type:Person
         isAccessibleForFree:
         hasPart:
            isAccessibleForFree:
            cssSelector:.main-content
            type:WebPageElement
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Lipoxygenase and Cyclooxygenase Pathways and Colorectal Cancer Prevention
      description:Colorectal cancer is one of the commonest malignancies in both men and women. In spite of significant progress in screening and in surgical and therapeutic interventions, colorectal cancer (CRC) is still a major public health problem. Accumulating evidence suggests that targeting inflammatory pathways may provide protection against the development of CRC. Eicosanoids derived from the enzymes cyclooxygenase (COX) and lipoxygenase (LOX) may contribute to CRC carcinogenesis. Approaches for targeting COX-1 and COX-2 with traditional nonsteroidal anti-inflammatory agents or targeting COX-2 with specific inhibitors are highly successful at the preclinical and clinical levels; however, large-scale clinical applicability of these agents is limited owing to unwanted side effects. Emerging studies suggests that 5-LOX-derived leukotrienes may contribute to colon tumor development and risk of thrombotic events. Thus, developing drugs that target both 5-LOX and COX-2 may provide a safer strategy. In this review, we discuss evidence for the involvement of 5-LOX in colon tumor development and targeting 5-LOX and COX-2 with synthetic and naturally occurring agents for CRC prevention.
      datePublished:2012-10-03T00:00:00Z
      dateModified:2012-10-03T00:00:00Z
      pageStart:316
      pageEnd:324
      sameAs:https://doi.org/10.1007/s11888-012-0146-1
      keywords:
         Lipoxygenase
         Cyclooxygenase
         Nonsteroidal anti-inflammatory drugs
         Eicosanoid
         Chemoprevention
         Dual cyclooxygenase/lipoxygenase inhibitors
         Curcumin
         Resolvins
         Omega-3 fatty acids
         Oncology
         Proctology
         Colorectal Surgery
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs11888-012-0146-1/MediaObjects/11888_2012_146_Fig1_HTML.gif
      isPartOf:
         name:Current Colorectal Cancer Reports
         issn:
            1556-3804
            1556-3790
         volumeNumber:8
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Current Science Inc.
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Chinthalapally V. Rao
            affiliation:
                  name:University of Oklahoma Health Sciences Center
                  address:
                     name:Center for Cancer Prevention and Drug Development, Medical Oncology, Department of Medicine, PC Stephenson Cancer Center, University of Oklahoma Health Sciences Center, Oklahoma City, USA
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
            name:Naveena B. Janakiram
            affiliation:
                  name:University of Oklahoma Health Sciences Center
                  address:
                     name:Center for Cancer Prevention and Drug Development, Medical Oncology, Department of Medicine, PC Stephenson Cancer Center, University of Oklahoma Health Sciences Center, Oklahoma City, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Altaf Mohammed
            affiliation:
                  name:University of Oklahoma Health Sciences Center
                  address:
                     name:Center for Cancer Prevention and Drug Development, Medical Oncology, Department of Medicine, PC Stephenson Cancer Center, University of Oklahoma Health Sciences Center, Oklahoma City, USA
                     type:PostalAddress
                  type:Organization
            type:Person
      isAccessibleForFree:
      hasPart:
         isAccessibleForFree:
         cssSelector:.main-content
         type:WebPageElement
["Periodical","PublicationVolume"]:
      name:Current Colorectal Cancer Reports
      issn:
         1556-3804
         1556-3790
      volumeNumber:8
Organization:
      name:Current Science Inc.
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:University of Oklahoma Health Sciences Center
      address:
         name:Center for Cancer Prevention and Drug Development, Medical Oncology, Department of Medicine, PC Stephenson Cancer Center, University of Oklahoma Health Sciences Center, Oklahoma City, USA
         type:PostalAddress
      name:University of Oklahoma Health Sciences Center
      address:
         name:Center for Cancer Prevention and Drug Development, Medical Oncology, Department of Medicine, PC Stephenson Cancer Center, University of Oklahoma Health Sciences Center, Oklahoma City, USA
         type:PostalAddress
      name:University of Oklahoma Health Sciences Center
      address:
         name:Center for Cancer Prevention and Drug Development, Medical Oncology, Department of Medicine, PC Stephenson Cancer Center, University of Oklahoma Health Sciences Center, Oklahoma City, USA
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Chinthalapally V. Rao
      affiliation:
            name:University of Oklahoma Health Sciences Center
            address:
               name:Center for Cancer Prevention and Drug Development, Medical Oncology, Department of Medicine, PC Stephenson Cancer Center, University of Oklahoma Health Sciences Center, Oklahoma City, USA
               type:PostalAddress
            type:Organization
      email:[email protected]
      name:Naveena B. Janakiram
      affiliation:
            name:University of Oklahoma Health Sciences Center
            address:
               name:Center for Cancer Prevention and Drug Development, Medical Oncology, Department of Medicine, PC Stephenson Cancer Center, University of Oklahoma Health Sciences Center, Oklahoma City, USA
               type:PostalAddress
            type:Organization
      name:Altaf Mohammed
      affiliation:
            name:University of Oklahoma Health Sciences Center
            address:
               name:Center for Cancer Prevention and Drug Development, Medical Oncology, Department of Medicine, PC Stephenson Cancer Center, University of Oklahoma Health Sciences Center, Oklahoma City, USA
               type:PostalAddress
            type:Organization
PostalAddress:
      name:Center for Cancer Prevention and Drug Development, Medical Oncology, Department of Medicine, PC Stephenson Cancer Center, University of Oklahoma Health Sciences Center, Oklahoma City, USA
      name:Center for Cancer Prevention and Drug Development, Medical Oncology, Department of Medicine, PC Stephenson Cancer Center, University of Oklahoma Health Sciences Center, Oklahoma City, USA
      name:Center for Cancer Prevention and Drug Development, Medical Oncology, Department of Medicine, PC Stephenson Cancer Center, University of Oklahoma Health Sciences Center, Oklahoma City, USA
WebPageElement:
      isAccessibleForFree:
      cssSelector:.main-content

External Links {🔗}(275)

Analytics and Tracking {📊}

Google Tag Manager

Libraries {📚}

Clipboard.js
Prism.js

4.81s.

LINK . SPRINGER . COM {}